miRagen Announces Initiation of Phase 1 Clinical Trial of MRG-110
miRagen Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today the initiation…
miRagen Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today the initiation…